3-D mammography clears FDA

Article

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University School of Medicine to Instrumentarium Imaging, is an integral part of the Delta 32 TACT 3-D breast imaging system, which will be available exclusively on Instrumentarium Imaging’s Diamond Breast Care System. Using TACT, Instrumentarium has also developed a dental imaging system and a computer program called CliniView.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.